Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07116733Phase 3Recruiting
A Phase 3 trial of desflurane in coronary artery disease (CAD), sponsored by Xijing Hospital. Started Oct 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07116733.